HUTCHMED DRC (HCM) Event Aug. 01, 2022, 11:33 UTC 10 1 comments (10% Negative) HUTCHMED DRC (HCM) Reports Q2 2022 Financial Results (Form 6-K) Comment Full text
ATAI Life Sciences (ATAI) Event Aug. 01, 2022, 11:31 UTC 13 1 comments (99% Neutral) ATAI LIFE SCIENCES N.V. (ATAI) Announces Business Combination Comment Full text
ObsEva SA (company was delisted NASDAQ) (OBSV) Event Aug. 01, 2022, 11:21 UTC 10 1 comments (99% Neutral) ObsEva SA (company was delisted NASDAQ) (OBSV) Announces Clinical Development Update (Form 6-K) Comment Full text
Tonix Pharmaceuticals Holding Corp (TNXP) Event Aug. 01, 2022, 11:07 UTC 13 1 comments (99% Neutral) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Announces Clinical Development Update Comment Full text
TherapeuticsMD Inc (TXMD) Event Aug. 01, 2022, 10:55 UTC 13 1 comments (35% Negative) TherapeuticsMD, Inc. (TXMD) Announces Business Combination Comment Full text
HUTCHMED DRC (HCM) Event Aug. 01, 2022, 10:53 UTC 10 1 comments (99% Neutral) HUTCHMED DRC (HCM) Announces Clinical Development Update (Form 6-K) Comment Full text
Beam Therapeutics Inc (BEAM) Event Aug. 01, 2022, 10:50 UTC 13 1 comments (10% Negative) Beam Therapeutics Inc. (BEAM) Announces Clinical Trial Timeline Adjustment Comment Full text
Cyteir Therapeutics (CYT) Event Aug. 01, 2022, 05:54 UTC 97 0 comments Cyteir Therapeutics - 2022 Wedbush PacGrow Healthcare Virtual Conference Comment Full text
Reata Pharmaceuticals Inc. (RETA) Event Aug. 01, 2022, 03:46 UTC 97 0 comments Reata Pharmaceuticals Inc. - Reata Pharmaceuticals Second Quarter 2022 Financial Results and Update on Development Programs Comment Full text
Lexicon Pharmaceuticals Inc. (LXRX) Event July 29, 2022, 21:18 UTC 11 1 comments (80% Positive) Lexicon Pharmaceuticals, Inc. (LXRX) Provides Update on sotagliflozin for sotagliflozin in heart failure Comment Full text